Publika - Scientific publications from Oslo University Hospital

RSS feed RSS

Publications (original articles or review articles) published in 2009 from OUS - Department of Cardiology Ullevaal (Div Med)

74 publications found

Aksnes TA, Kjeldsen SE, Schmieder RE (2009)
Hypertension and atrial fi brillation with emphasis on prevention
Blood Press, 18 (3), 94-8
DOI 10.1080/08037050903040744, PubMed 20499443

Andersson KB, Birkeland JA, Finsen AV, Louch WE, Sjaastad I, Wang Y, Chen J, Molkentin JD, Chien KR, Sejersted OM, Christensen G (2009)
Moderate heart dysfunction in mice with inducible cardiomyocyte-specific excision of the Serca2 gene
J Mol Cell Cardiol, 47 (2), 180-7
DOI 10.1016/j.yjmcc.2009.03.013, PubMed 19328205

Angel K, Provan SA, Gulseth HL, Mowinckel P, Kvien TK, Atar D (2009)
Tumor necrosis factor-alpha antagonists improve aortic stiffness in patients with inflammatory arthropathies: a controlled study
Hypertension, 55 (2), 333-8
DOI 10.1161/HYPERTENSIONAHA.109.143982, PubMed 20038753

Atar D, Carmena R, Clemmensen P, K-Laflamme A, Wassmann S, Lansberg P, Hobbs R (2009)
Clinical review: impact of statin substitution policies on patient outcomes
Ann Med, 41 (4), 242-56
DOI 10.1080/07853890902729786, PubMed 19191052

Atar D, Petzelbauer P, Schwitter J, Huber K, Rensing B, Kasprzak JD, Butter C, Grip L, Hansen PR, Süselbeck T, Clemmensen PM, Marin-Galiano M, Geudelin B, Buser PT, F.I.R.E. Investigators (2009)
Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction results of the F.I.R.E. (Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury) trial
J Am Coll Cardiol, 53 (8), 720-9
DOI 10.1016/j.jacc.2008.12.017, PubMed 19232907

Banach M, Mikhailidis DP, Kjeldsen SE, Rysz J (2009)
Time for new indications for statins?
Med Sci Monit, 15 (12), MS1-5
PubMed 19946240

Beitnes JO, Hopp E, Lunde K, Solheim S, Arnesen H, Brinchmann JE, Forfang K, Aakhus S (2009)
Long-term results after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: the ASTAMI randomised, controlled study
Heart, 95 (24), 1983-9
DOI 10.1136/hrt.2009.178913, PubMed 19833610

Brandsaeter B, Atar D, Agewall S, Norwegian Heart failure Registry (2009)
Gender differences among Norwegian patients with heart failure
Int J Cardiol, 146 (3), 354-8
DOI 10.1016/j.ijcard.2009.07.014, PubMed 19700210

Bøhmer E, Hoffmann P, Abdelnoor M, Arnesen H, Halvorsen S (2009)
Efficacy and safety of immediate angioplasty versus ischemia-guided management after thrombolysis in acute myocardial infarction in areas with very long transfer distances results of the NORDISTEMI (NORwegian study on DIstrict treatment of ST-elevation myocardial infarction)
J Am Coll Cardiol, 55 (2), 102-10
DOI 10.1016/j.jacc.2009.08.007, PubMed 19747792

Bøhmer E, Hoffmann P, Abdelnoor M, Seljeflot I, Halvorsen S (2009)
Troponin T concentration 3 days after acute ST-elevation myocardial infarction predicts infarct size and cardiac function at 3 months
Cardiology, 113 (3), 207-12
DOI 10.1159/000201991, PubMed 19218804

Crisby M, Kublickiene K, Henareh L, Agewall S (2009)
Circulating levels of autoantibodies to oxidized low-density lipoprotein and C-reactive protein levels correlate with endothelial function in resistance arteries in men with coronary heart disease
Heart Vessels, 24 (2), 90-5
DOI 10.1007/s00380-008-1089-y, PubMed 19337791

de Simone G, Okin PM, Gerdts E, Olsen MH, Wachtell K, Hille DA, Dahlöf B, Kjeldsen SE, Devereux RB (2009)
Clustered metabolic abnormalities blunt regression of hypertensive left ventricular hypertrophy: the LIFE study
Nutr Metab Cardiovasc Dis, 19 (9), 634-40
DOI 10.1016/j.numecd.2008.12.012, PubMed 19361968

Diette GB, Sajjan SG, Skinner EA, Weiss TW, Wu AW, Markson LE (2009)
Using the pediatric asthma therapy assessment questionnaire to measure asthma control and healthcare utilization in children
Patient, 2 (4), 233-41
DOI 10.2165/11313820-000000000-00000, PubMed 22273244

Einvik G, Ekeberg O, Klemsdal TO, Sandvik L, Hjerkinn EM (2009)
Physical distress is associated with cardiovascular events in a high risk population of elderly men
BMC Cardiovasc Disord, 9, 14
DOI 10.1186/1471-2261-9-14, PubMed 19331677

Einvik G, Ekeberg O, Lavik JG, Ellingsen I, Klemsdal TO, Hjerkinn EM (2009)
The influence of long-term awareness of hyperlipidemia and of 3 years of dietary counseling on depression, anxiety, and quality of life
J Psychosom Res, 68 (6), 567-72
DOI 10.1016/j.jpsychores.2009.11.004, PubMed 20488274

Faizi AK, Kornmo DW, Agewall S (2009)
Evaluation of endothelial function using finger plethysmography
Clin Physiol Funct Imaging, 29 (5), 372-5
DOI 10.1111/j.1475-097X.2009.00882.x, PubMed 19552735

Furenes EB, Arnesen H, Solheim S, Grøgaard HK, Hoffmann P, Seljeflot I (2009)
The profile of circulating metalloproteinases after PCI in patients with acute myocardial infarction or stable angina
Thromb Res, 124 (5), 560-4
DOI 10.1016/j.thromres.2009.04.001, PubMed 19410278

Grimsmo J, Arnesen H, Maehlum S (2009)
Changes in cardiorespiratory function in different groups of former and still active male cross-country skiers: a 28-30-year follow-up study
Scand J Med Sci Sports, 20 (1), e151-61
DOI 10.1111/j.1600-0838.2009.00931.x, PubMed 19422661

Gudmundsdottir H, Taarnhøj NC, Strand AH, Kjeldsen SE, Høieggen A, Os I (2009)
Blood pressure development and hypertensive retinopathy: 20-year follow-up of middle-aged normotensive and hypertensive men
J Hum Hypertens, 24 (8), 505-13
DOI 10.1038/jhh.2009.94, PubMed 20010619

Hallén J, Buser P, Schwitter J, Petzelbauer P, Geudelin B, Fagerland MW, Jaffe AS, Atar D (2009)
Relation of cardiac troponin I measurements at 24 and 48 hours to magnetic resonance-determined infarct size in patients with ST-elevation myocardial infarction
Am J Cardiol, 104 (11), 1472-7
DOI 10.1016/j.amjcard.2009.07.019, PubMed 19932777

Halvorsen S, Eritsland J, Abdelnoor M, Holst Hansen C, Risøe C, Midtbø K, Bjørnerheim R, Mangschau A (2009)
Gender differences in management and outcome of acute myocardial infarctions treated in 2006-2007
Cardiology, 114 (2), 83-8
DOI 10.1159/000216582, PubMed 19420934

Halvorsen S, Risøe C (2009)
[Symptoms and diagnosis of coronary heart disease in women]
Tidsskr Nor Laegeforen, 129 (18), 1853-7
DOI 10.4045/tidsskr.09.0115, PubMed 19844276

Hassellund SS, Flaa A, Sandvik L, Kjeldsen SE, Rostrup M (2009)
Long-term stability of cardiovascular and catecholamine responses to stress tests: an 18-year follow-up study
Hypertension, 55 (1), 131-6
DOI 10.1161/HYPERTENSIONAHA.109.143164, PubMed 19948985

Hegbom F, Tveit A, Grundvold I, Arnesen H, Smith P (2009)
Effects of angiotensin receptor blockade on serial P-wave signal-averaged electrocardiograms after electrical cardioversion of persistent atrial fibrillation
Europace, 11 (10), 1301-7
DOI 10.1093/europace/eup220, PubMed 19666643

Henareh L, Jogestrand T, Agewall S (2009)
Prothrombin fragment 1 + 2 is associated with intima media thickness of the carotid artery in patients with myocardial infarction
Thromb Res, 124 (5), 526-30
DOI 10.1016/j.thromres.2009.03.014, PubMed 19427679

Huikuri HV, Raatikainen MJ, Moerch-Joergensen R, Hartikainen J, Virtanen V, Boland J, Anttonen O, Hoest N, Boersma LV, Platou ES, Messier MD, Bloch-Thomsen PE, Cardiac Arrhythmias and Risk Stratification after Acute Myocardial Infarction study group (2009)
Prediction of fatal or near-fatal cardiac arrhythmia events in patients with depressed left ventricular function after an acute myocardial infarction
Eur Heart J, 30 (6), 689-98
DOI 10.1093/eurheartj/ehn537, PubMed 19155249

Hussain RI, Qvigstad E, Birkeland JA, Eikemo H, Glende A, Sjaastad I, Skomedal T, Osnes JB, Levy FO, Krobert KA (2009)
Activation of muscarinic receptors elicits inotropic responses in ventricular muscle from rats with heart failure through myosin light chain phosphorylation
Br J Pharmacol, 156 (4), 575-86
DOI 10.1111/j.1750-3639.2009.00016.x, PubMed 19159405

Iversen PO, Andersson KB, Finsen AV, Sjaastad I, von Lueder TG, Sejersted OM, Attramadal H, Christensen G (2009)
Separate mechanisms cause anemia in ischemic vs. nonischemic murine heart failure
Am J Physiol Regul Integr Comp Physiol, 298 (3), R808-14
DOI 10.1152/ajpregu.00250.2009, PubMed 20032264

Jarai R, Kaun C, Weiss TW, Speidl WS, Rychli K, Maurer G, Huber K, Wojta J (2009)
Human cardiac fibroblasts express B-type natriuretic peptide: fluvastatin ameliorates its up-regulation by interleukin-1alpha, tumour necrosis factor-alpha and transforming growth factor-beta
J Cell Mol Med, 13 (11-12), 4415-21
DOI 10.1111/j.1582-4934.2009.00704.x, PubMed 19228263

Jensen JK, Ueland T, Atar D, Gullestad L, Mickley H, Aukrust P, Januzzi JL (2009)
Osteoprotegerin concentrations and prognosis in acute ischaemic stroke
J Intern Med, 267 (4), 410-7
DOI 10.1111/j.1365-2796.2009.02163.x, PubMed 19895657

Johannessen A, Trøseid M, Calmy A (2009)
Dried blood spots can expand access to virological monitoring of HIV treatment in resource-limited settings
J Antimicrob Chemother, 64 (6), 1126-9
DOI 10.1093/jac/dkp353, PubMed 19776036

Kjekshus JK, Torp-Pedersen C, Gullestad L, Køber L, Edvardsen T, Olsen IC, Sjaastad I, Qvigstad E, Skomedal T, Osnes JB, Levy FO (2009)
Effect of piboserod, a 5-HT4 serotonin receptor antagonist, on left ventricular function in patients with symptomatic heart failure
Eur J Heart Fail, 11 (8), 771-8
DOI 10.1093/eurjhf/hfp087, PubMed 19567409

Kjeldsen SE, Devereux RB, Hille DA, Lyle PA, Dahlöf B, Julius S, Edelman JM, Snapinn SM, de Faire U, Fyhrquist F, Ibsen H, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H (2009)
Predictors of cardiovascular events in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention for Endpoint reduction in hypertension study
Blood Press, 18 (6), 348-61
DOI 10.3109/08037050903460590, PubMed 20001655

Kjeldsen SE, Stålhammar J, Hasvold P, Bodegard J, Olsson U, Russell D (2009)
Effects of losartan vs candesartan in reducing cardiovascular events in the primary treatment of hypertension
J Hum Hypertens, 24 (4), 263-73
DOI 10.1038/jhh.2009.77, PubMed 19890371

Knudsen EC, Seljeflot I, Abdelnoor M, Eritsland J, Mangschau A, Arnesen H, Andersen GO (2009)
Abnormal glucose regulation in patients with acute ST- elevation myocardial infarction-a cohort study on 224 patients
Cardiovasc Diabetol, 8, 6
DOI 10.1186/1475-2840-8-6, PubMed 19183453

Kuliczkowski W, Witkowski A, Polonski L, Watala C, Filipiak K, Budaj A, Golanski J, Sitkiewicz D, Pregowski J, Gorski J, Zembala M, Opolski G, Huber K, Arnesen H, Kristensen SD, De Caterina R (2009)
Interindividual variability in the response to oral antiplatelet drugs: a position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of Cardiology
Eur Heart J, 30 (4), 426-35
DOI 10.1093/eurheartj/ehn562, PubMed 19174428

Lie I, Arnesen H, Sandvik L, Hamilton G, Bunch EH (2009)
Health-related quality of life after coronary artery bypass grafting. The impact of a randomised controlled home-based intervention program
Qual Life Res, 18 (2), 201-7
DOI 10.1007/s11136-008-9438-y, PubMed 19169899

Lip GY, Huber K, Andreotti F, Arnesen H, Airaksinen KJ, Cuisset T, Kirchhof P, Marín F, European Society of Cardiology Working Group on Thrombosis (2009)
Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary intervention/ stenting
Thromb Haemost, 103 (1), 13-28
DOI 10.1160/TH09-08-0580, PubMed 20062939

Louch WE, Hougen K, Mørk HK, Swift F, Aronsen JM, Sjaastad I, Reims HM, Roald B, Andersson KB, Christensen G, Sejersted OM (2009)
Sodium accumulation promotes diastolic dysfunction in end-stage heart failure following Serca2 knockout
J Physiol, 588 (Pt 3), 465-78
DOI 10.1113/jphysiol.2009.183517, PubMed 20008467

Madsen LH, Lund T, Grieg Z, Nygaard S, Holmvang L, Jurlander B, Grande P, Christensen G, Atar D (2009)
Cardiac troponin I degradation in serum of patients with hypertrophic obstructive cardiomyopathy undergoing percutaneous septal ablation
Cardiology, 114 (3), 167-73
DOI 10.1159/000226596, PubMed 19571537

Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, Cifkova R, Clément D, Coca A, Dominiczak A, Erdine S, Fagard R, Farsang C, Grassi G, Haller H, Heagerty A, Kjeldsen SE, Kiowski W, Mallion JM, Manolis A, Narkiewicz K, Nilsson P, Olsen MH, Rahn KH, Redon J et al. (2009)
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document
Blood Press, 18 (6), 308-47
DOI 10.3109/08037050903450468, PubMed 20001654

Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, Cifkova R, Clément D, Coca A, Dominiczak A, Erdine S, Fagard R, Farsang C, Grassi G, Haller H, Heagerty A, Kjeldsen SE, Kiowski W, Mallion JM, Manolis A, Narkiewicz K, Nilsson P, Olsen MH, Rahn KH, Redon J et al. (2009)
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document
J Hypertens, 27 (11), 2121-58
DOI 10.1097/HJH.0b013e328333146d, PubMed 19838131

Morin DP, Oikarinen L, Viitasalo M, Toivonen L, Nieminen MS, Kjeldsen SE, Dahlöf B, John M, Devereux RB, Okin PM (2009)
QRS duration predicts sudden cardiac death in hypertensive patients undergoing intensive medical therapy: the LIFE study
Eur Heart J, 30 (23), 2908-14
DOI 10.1093/eurheartj/ehp321, PubMed 19687165

Mørk HK, Sjaastad I, Sejersted OM, Louch WE (2009)
Slowing of cardiomyocyte Ca2+ release and contraction during heart failure progression in postinfarction mice
Am J Physiol Heart Circ Physiol, 296 (4), H1069-79
DOI 10.1152/ajpheart.01009.2008, PubMed 19201998

Okin PM, Devereux RB, Kjeldsen SE, Edelman JM, Dahlöf B (2009)
Incidence of heart failure in relation to QRS duration during antihypertensive therapy: the LIFE study
J Hypertens, 27 (11), 2271-7
DOI 10.1097/HJH.0b013e328330b66b, PubMed 19834342

Okin PM, Oikarinen L, Viitasalo M, Toivonen L, Kjeldsen SE, Nieminen MS, Edelman JM, Dahlöf B, Devereux RB, LIFE Study Investigators (2009)
Prognostic value of changes in the electrocardiographic strain pattern during antihypertensive treatment: the Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE)
Circulation, 119 (14), 1883-91
DOI 10.1161/CIRCULATIONAHA.108.812313, PubMed 19332468

Olsen MH, Wachtell K, Beevers G, Dahlöf B, de Simone G, Devereux RB, de Faire U, Fyhrquist F, Ibsen H, Kjeldsen SE, Lederballe-Pedersen O, Lindholm LH, Lyle PA, Nieminen MS, Omvik P, Oparil S, Wedel H (2009)
Effects of losartan compared with atenolol on lipids in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study
J Hypertens, 27 (3), 567-74
DOI 10.1097/HJH.0b013e32831daf96, PubMed 19262226

Pahle AS, Sørli D, Omland T, Knudsen CW, Westheim A, Wu AH, Steg PG, McCord J, Nowak RM, Hollander JE, Storrow AB, Abraham WT, McCullough PA, Maisel A (2009)
Impact of systemic hypertension on the diagnostic performance of B-type natriuretic peptide in patients with acute dyspnea
Am J Cardiol, 104 (7), 966-71
DOI 10.1016/j.amjcard.2009.05.039, PubMed 19766765

Paier A, Agewall S, Kublickiene K (2009)
Expression of heat shock proteins and nitrotyrosine in small arteries from patients with coronary heart disease
Heart Vessels, 24 (4), 260-6
DOI 10.1007/s00380-008-1117-y, PubMed 19626397

Qvigstad E, Moltzau LR, Aronsen JM, Nguyen CH, Hougen K, Sjaastad I, Levy FO, Skomedal T, Osnes JB (2009)
Natriuretic peptides increase beta1-adrenoceptor signalling in failing hearts through phosphodiesterase 3 inhibition
Cardiovasc Res, 85 (4), 763-72
DOI 10.1093/cvr/cvp364, PubMed 19900965

Rehn TA, Borge BA, Lunde PK, Munkvik M, Sneve ML, Grøndahl F, Aronsen JM, Sjaastad I, Prydz K, Kolset SO, Wiig H, Sejersted OM, Iversen PO (2009)
Temporary fatigue and altered extracellular matrix in skeletal muscle during progression of heart failure in rats
Am J Physiol Regul Integr Comp Physiol, 297 (1), R26-33
DOI 10.1152/ajpregu.90617.2008, PubMed 19339678

Rud B, Christensen CC, Ryg M, Edvardsen A, Skumlien S, Hallén J (2009)
Higher skeletal muscular metabolic reserve capacity in COPD patients than healthy subjects
Scand J Med Sci Sports, 19 (6), 857-64
DOI 10.1111/j.1600-0838.2008.00846.x, PubMed 19508654

Sanner H, Gran JT, Sjaastad I, Flatø B (2009)
Cumulative organ damage and prognostic factors in juvenile dermatomyositis: a cross-sectional study median 16.8 years after symptom onset
Rheumatology (Oxford), 48 (12), 1541-7
DOI 10.1093/rheumatology/kep302, PubMed 19776224

Sanner K, Wikström I, Strand A, Lindell M, Wilander E (2009)
Self-sampling of the vaginal fluid at home combined with high-risk HPV testing
Br J Cancer, 101 (5), 871-4
DOI 10.1038/sj.bjc.6605194, PubMed 19654577

Serebruany V, Cherala G, Williams C, Surigin S, Booze C, Kuliczkowski W, Atar D (2009)
Association of platelet responsiveness with clopidogrel metabolism: role of compliance in the assessment of "resistance"
Am Heart J, 158 (6), 925-32
DOI 10.1016/j.ahj.2009.10.012, PubMed 19958858

Serebruany V, Rao SV, Silva MA, Donovan JL, Kannan AO, Makarov L, Goto S, Atar D (2009)
Correlation of inhibition of platelet aggregation after clopidogrel with post discharge bleeding events: assessment by different bleeding classifications
Eur Heart J, 31 (2), 227-35
DOI 10.1093/eurheartj/ehp434, PubMed 19854728

Sharikabad MN, Aronsen JM, Haugen E, Pedersen J, Møller AS, Mørk HK, Aass HC, Sejersted OM, Sjaastad I, Brørs O (2009)
Cardiomyocytes from postinfarction failing rat hearts have improved ischemia tolerance
Am J Physiol Heart Circ Physiol, 296 (3), H787-95
DOI 10.1152/ajpheart.00796.2008, PubMed 19136604

Slot KB, Berge E (2009)
Thrombolytic treatment for stroke: patient preferences for treatment, information, and involvement
J Stroke Cerebrovasc Dis, 18 (1), 17-22
DOI 10.1016/j.jstrokecerebrovasdis.2008.06.009, PubMed 19110139

Slot KB, Berge E, Sandercock P, Lewis SC, Dorman P, Dennis M, Oxfordshire Community Stroke Project, Lothian Stroke Register, International Stroke Trial (UK) (2009)
Causes of death by level of dependency at 6 months after ischemic stroke in 3 large cohorts
Stroke, 40 (5), 1585-9
DOI 10.1161/STROKEAHA.108.531533, PubMed 19265057

Stepien M, Banach M, Mikhailidis DP, Gluba A, Kjeldsen SE, Rysz J (2009)
Role and significance of statins in the treatment of hypertensive patients
Curr Med Res Opin, 25 (8), 1995-2005
DOI 10.1185/03007990903098081, PubMed 19555312

Stokke MK, Hougen K, Sjaastad I, Louch WE, Briston SJ, Enger UH, Andersson KB, Christensen G, Eisner DA, Sejersted OM, Trafford AW (2009)
Reduced SERCA2 abundance decreases the propensity for Ca2+ wave development in ventricular myocytes
Cardiovasc Res, 86 (1), 63-71
DOI 10.1093/cvr/cvp401, PubMed 20019150

Taraldsrud E, Grøgaard HK, Solheim S, Lunde K, Fløisand Y, Arnesen H, Seljeflot I, Egeland T (2009)
Age and stress related phenotypical changes in bone marrow CD34+ cells
Scand J Clin Lab Invest, 69 (1), 79-84
DOI 10.1080/00365510802419447, PubMed 18836945

Task Force for the Diagnosis and Management of Syncope, European Society of Cardiology (ESC), European Heart Rhythm Association (EHRA), Heart Failure Association (HFA), Heart Rhythm Society (HRS), Moya A, Sutton R, Ammirati F, Blanc JJ, Brignole M, Dahm JB, Deharo JC, Gajek J, Gjesdal K, Krahn A, Massin M, Pepi M, Pezawas T, Ruiz Granell R, Sarasin F, Ungar A, van Dijk JG, Walma EP, Wieling W (2009)
Guidelines for the diagnosis and management of syncope (version 2009)
Eur Heart J, 30 (21), 2631-71
DOI 10.1093/eurheartj/ehp298, PubMed 19713422

Tjugen TB, Flaa A, Kjeldsen SE (2009)
High heart rate as predictor of essential hypertension: the hyperkinetic state, evidence of prediction of hypertension, and hemodynamic transition to full hypertension
Prog Cardiovasc Dis, 52 (1), 20-5
DOI 10.1016/j.pcad.2009.05.008, PubMed 19615489

Trøseid M, Arnesen H, Hjerkinn EM, Seljeflot I (2009)
Serum levels of interleukin-18 are reduced by diet and n-3 fatty acid intervention in elderly high-risk men
Metabolism, 58 (11), 1543-9
DOI 10.1016/j.metabol.2009.04.031, PubMed 19595382

Trøseid M, Eskesen A, Bruun JN (2009)
[Immune reconstitution inflammatory syndrome and treatment of HIV infection]
Tidsskr Nor Laegeforen, 129 (23), 2484-7
DOI 10.4045/tidsskr.09.0190, PubMed 19997137

Trøseid M, Lappegård KT, Mollnes TE, Arnesen H, Seljeflot I (2009)
The effect of exercise on serum levels of interleukin-18 and components of the metabolic syndrome
Metab Syndr Relat Disord, 7 (6), 579-84
DOI 10.1089/met.2009.0003, PubMed 19900154

Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, Filippatos G, Fox K, Huber K, Kastrati A, Rosengren A, Steg PG, Tubaro M, Verheugt F, Weidinger F, Weis M, Task Force per il Trattamento dell'Infarto Miocardico Acuto con, Sopraslivellamento del Tratto ST della Società Europea di Cardiologia, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C et al. (2009)
[Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation]
G Ital Cardiol (Rome), 10 (7), 450-89
PubMed 19761103

Wahlstrand B, Orho-Melander M, Delling L, Kjeldsen S, Narkiewicz K, Almgren P, Hedner T, Melander O (2009)
The myocardial infarction associated CDKN2A/CDKN2B locus on chromosome 9p21 is associated with stroke independently of coronary events in patients with hypertension
J Hypertens, 27 (4), 769-73
DOI 10.1097/HJH.0b013e328326f7eb, PubMed 19293724

Wardlaw JM, Murray V, Berge E, Del Zoppo GJ (2009)
Thrombolysis for acute ischaemic stroke
Cochrane Database Syst Rev (4), CD000213
DOI 10.1002/14651858.CD000213.pub2, PubMed 19821269

Wennersberg MH, Smedman A, Turpeinen AM, Retterstøl K, Tengblad S, Lipre E, Aro A, Mutanen P, Seljeflot I, Basu S, Pedersen JI, Mutanen M, Vessby B (2009)
Dairy products and metabolic effects in overweight men and women: results from a 6-mo intervention study
Am J Clin Nutr, 90 (4), 960-8
DOI 10.3945/ajcn.2009.27664, PubMed 19710195

Yndestad A, Larsen KO, Oie E, Ueland T, Smith C, Halvorsen B, Sjaastad I, Skjønsberg OH, Pedersen TM, Anfinsen OG, Damås JK, Christensen G, Aukrust P, Andreassen AK (2009)
Elevated levels of activin A in clinical and experimental pulmonary hypertension
J Appl Physiol (1985), 106 (4), 1356-64
DOI 10.1152/japplphysiol.90719.2008, PubMed 19196915

Zanchetti A, Mancia G, Black HR, Oparil S, Waeber B, Schmieder RE, Bakris GL, Messerli FH, Kjeldsen SE, Ruilope LM (2009)
Facts and fallacies of blood pressure control in recent trials: implications in the management of patients with hypertension
J Hypertens, 27 (4), 673-9
DOI 10.1097/HJH.0b013e3283298ea2, PubMed 19516168

Zidek W, Naditch-Brûlé L, Perlini S, Farsang C, Kjeldsen SE (2009)
Blood pressure control and components of the metabolic syndrome: the GOOD survey
Cardiovasc Diabetol, 8, 51
DOI 10.1186/1475-2840-8-51, PubMed 19754934

0.16s